AXE 1.96% 26.0¢ archer materials limited

Thanks @rambleon for the Pitt Street Research update.A very...

  1. 1,234 Posts.
    lightbulb Created with Sketch. 2745

    Thanks @rambleon for the Pitt Street Research update.

    A very interesting read of the optics and AXE's potential, including:

    'We continue to observe that relevant ASX peers trade at valuations that are clearly higher than Archer Materials’

    Amongst the many comprehensive points made, Pitt Street state that a major share price catalyst could come from the development of partnerships with leading semiconductor, technology, and life sciences companies that will likely provide validation of Archer Materials’ technologies. IMO, this could eventuate at anytime throughout rest of the year.

    What was most interesting was the discussion around the Australian Federal and State governments bet on PsiQuantum. This gets a comprehensive workout. In particular, they confirm that Archer is not as behind as investors may think and that they are well on track to deliver on multiple milestones. Following is an excerpt from the research:

    PsiQuantum: What the investment [governments] means for Archer Materials
    Investors in Archer Materials raised plenty of eyebrows over the A$940m PsiQuantum investment. They may think that the investment means either Archer Materials is currently behind PsiQuantum or that at least the Australian and Queensland governments think it is. But either way, the (wrong) consensus is that Archer Materials will lag PsiQuantum because it received this money.

    While no one can control private perceptions of government officials, it is not the case that Archer Materials is necessarily behind PsiQuantum. All quantum players are at an R&D phase and are at least a few years away from commercialisation (note 23). This rings true even with major technology companies, like Microsoft and IBM, with established businesses that can help fund their own quantum aspirations. No doubt A$940m would make a difference to any quantum computing aspirant, and it will to PsiQuantum. But we believe the investment is about more than just one company, it is about the whole ecosystem, which will derive benefit, including for Archer.

    The Dunning-Kruger effect, in my opinion, favours AXE. If the government has overestimated PsiQuantum's capabilities, we may be largely more successful mainly because our skilled personnel don't have a reputation or credibility to lose. Rather, we stand to gain nothing and everything, which is why I'm content to keep backing this horse and let nature tell us who's spin up.

    All IMO, DYOR, GLTA(patient)H

    Last edited by Mallyrock: 03/07/24
 
watchlist Created with Sketch. Add AXE (ASX) to my watchlist
(20min delay)
Last
26.0¢
Change
0.005(1.96%)
Mkt cap ! $66.26M
Open High Low Value Volume
25.5¢ 26.0¢ 25.5¢ $25.66K 99.40K

Buyers (Bids)

No. Vol. Price($)
3 49536 25.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 27624 3
View Market Depth
Last trade - 13.39pm 27/08/2024 (20 minute delay) ?
AXE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.